Atopic Dermatitis Drugs Market (Drug Type: Corticosteroids, PDE4 Inhibitors, Biologics, Skin Barrier Emollients, CNI Immunosuppressants, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Aug 2022| TMR3249A| Transparency

Report Highlights

Atopic Dermatitis Drugs Market – Scope of Report

TMR’s report on the global atopic dermatitis drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global atopic dermatitis drugs market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global atopic dermatitis drugs market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the atopic dermatitis drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global atopic dermatitis drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global atopic dermatitis drugs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global atopic dermatitis drugs market.

The report delves into the competitive landscape of the global atopic dermatitis drugs market. Key players operating in the global atopic dermatitis drugs market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global atopic dermatitis drugs market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market atopic dermatitis drugs.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • WorldWideScience.org
  • Elsevier, Inc.
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

Frequently Asked Questions (FAQs)

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 2 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
  • Table 3 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 4 : North America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 5 : North America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 6 : North America Atopic Dermatitis Drugs Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 7 : Europe Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 8 : Europe Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 9 : Europe Atopic Dermatitis Drugs Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 10 : Asia Pacific Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 11 : Asia Pacific Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 12 : Asia Pacific Atopic Dermatitis Drugs Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 13 : Latin America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 14 : Latin America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 15 : Latin America Atopic Dermatitis Drugs Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 16 : Middle East and Africa Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 17 : Middle East and Africa Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017–2031
  • Table 18 : Middle East and Africa Atopic Dermatitis Drugs Market (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Figure 1 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 2 : Global Atopic Dermatitis Drugs Market Value Share Analysis, by Drug Type, 2021 and 2031
  • Figure 3 : Global Atopic Dermatitis Drugs Market Attractiveness Analysis, by Drug Type, 2022–2031
  • Figure 4 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2031
  • Figure 5 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by PDE4 Inhibitors, 2017–2031
  • Figure 6 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Biologics, 2017–2031
  • Figure 7 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Skin Barrier Emollients, 2017–2031
  • Figure 8 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, CNI Immunosuppressants, 2017–2031
  • Figure 9 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Others, 2017–2031
  • Figure 10 : Global Atopic Dermatitis Drugs Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 11 : Global Atopic Dermatitis Drugs Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 12 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Hospital Pharmacies, 2017–2031
  • Figure 13 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Retail Pharmacies, 2017–2031
  • Figure 14 : Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Online Pharmacies, 2017–2031
  • Figure 15 : Global Atopic Dermatitis Drugs Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 16 : Global Atopic Dermatitis Drugs Market Attractiveness Analysis, by Region, 2022–2031
  • Figure 17 : North America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 18 : North America Atopic Dermatitis Drugs Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 19 : North America Atopic Dermatitis Drugs Market Attractiveness Analysis, by Country, 2022–2031
  • Figure 20 : North America Atopic Dermatitis Drugs Market Value Share Analysis, by Drug Type, 2021 and 2031
  • Figure 21 : North America Atopic Dermatitis Drugs Market Attractiveness Analysis, by Drug Type, 2022–2031
  • Figure 22 : North America Atopic Dermatitis Drugs Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 23 : North America Atopic Dermatitis Drugs Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 24 : Europe Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 25 : Europe Atopic Dermatitis Drugs Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 26 : Europe Atopic Dermatitis Drugs Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 27 : Europe Atopic Dermatitis Drugs Market Value Share Analysis, by Drug Type, 2021 and 2031
  • Figure 28 : Europe Atopic Dermatitis Drugs Market Attractiveness Analysis, by Drug Type, 2022–2031
  • Figure 29 : Europe Atopic Dermatitis Drugs Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 30 : Europe Atopic Dermatitis Drugs Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 31 : Asia Pacific Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 32 : Asia Pacific Atopic Dermatitis Drugs Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 33 : Asia Pacific Atopic Dermatitis Drugs Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 34 : Asia Pacific Atopic Dermatitis Drugs Market Value Share Analysis, by Drug Type, 2021 and 2031
  • Figure 35 : Asia Pacific Atopic Dermatitis Drugs Market Attractiveness Analysis, by Drug Type, 2022–2031
  • Figure 36 : Asia Pacific Atopic Dermatitis Drugs Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 37 : Asia Pacific Atopic Dermatitis Drugs Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 38 : Latin America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 39 : Latin America Atopic Dermatitis Drugs Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 40 : Latin America Atopic Dermatitis Drugs Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 41 : Latin America Atopic Dermatitis Drugs Market Value Share Analysis, by Drug Type, 2021 and 2031
  • Figure 42 : Latin America Atopic Dermatitis Drugs Market Attractiveness Analysis, by Drug Type, 2022–2031
  • Figure 43 : Latin America Atopic Dermatitis Drugs Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 44 : Latin America Atopic Dermatitis Drugs Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 45 : Middle East and Africa Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 46 : Middle East and Africa Atopic Dermatitis Drugs Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 47 : Middle East and Africa Atopic Dermatitis Drugs Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 48 : Middle East and Africa Atopic Dermatitis Drugs Market Value Share Analysis, by Drug Type, 2021 and 2031
  • Figure 49 : Middle East and Africa Atopic Dermatitis Drugs Market Attractiveness Analysis, by Drug Type, 2022–2031
  • Figure 50 : Middle East and Africa Atopic Dermatitis Drugs Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 51 : Middle East and Africa Atopic Dermatitis Drugs Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Transparency
Price: $5795

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS